Gene · 1909
Papers4,314
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 4,314
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Large-scale multi-omics identifies drug targets for heart failure with reduced and preserved ejection fraction. | Nat Cardiovasc Res | 2025 | 39915329 | PubTator, text mining | PubMed |
| First real-world evidence of sparsentan efficacy in patients with IgA nephropathy treated with SGLT2 inhibitors. | Clin Kidney J | 2025 | 39872637 | PubTator, text mining | PubMed |
| Creating coveted bioluminescence colors for simultaneous multi-color bioimaging. | Sci Adv | 2025 | 39841832 | PubTator, text mining | PubMed |
| Endogenous hydrogen sulfide persulfidates endothelin type A receptor to inhibit pulmonary arterial smooth muscle cell proliferation. | Redox Biol | 2025 | 39823888 | PubTator, text mining | PubMed |
| Noncanonical RGS14 structural determinants control hormone-sensitive NPT2A-mediated phosphate transport. | Biochem J | 2025 | 39792018 | PubTator, text mining | PubMed |
| Association of endothelial nitric oxide synthase (NOS3) rs2070744 variant with advanced retinopathy of prematurity: a case-control study and meta-analysis. | Sci Rep | 2025 | 39747280 | PubTator, text mining | PubMed |
| Dimethyltryptamine (DMT) and ibogaine elicit membrane effects in HEK cells transiently transfected with the human 5-HT2A receptor. | Brain Res | 2025 | 39732157 | PubTator, text mining | PubMed |
| Absence of Functional Autoantibodies Targeting Angiotensin II Receptor Type 1 and Endothelin-1 Type A Receptor in Circulation and Purified IgG From Patients With Systemic Sclerosis. | Arthritis Rheumatol | 2025 | 39721751 | PubTator, text mining | PubMed |
| Mitochondrial A3 Adenosine Receptor as a Mechanism for the Protective Effects of A3AR Agonists on Chemotherapy-Induced Neuropathic Pain. | J Neurosci | 2025 | 39653498 | PubTator, text mining | PubMed |
| Corrigendum to "Regulation of extracellular matrix degradation and metastatic spread by IQGAP1 through endothelin-1 receptor signalling in ovarian cancer" [Matrix Biol. 81 (2019) 17-33]. | Matrix Biol | 2025 | 39592369 | PubTator, text mining | PubMed |
| FunCoup 6: advancing functional association networks across species with directed links and improved user experience. | Nucleic Acids Res | 2025 | 39530220 | PubTator, text mining | PubMed |
| Machine learning-based identification and validation of immune-related biomarkers for early diagnosis and targeted therapy in diabetic retinopathy. | Gene | 2025 | 39427825 | PubTator, text mining | PubMed |
| Altered Balance between Vasoconstrictor and Vasodilator Systems in Experimental Hypertension. | Physiol Res | 2024 | 39903883 | PubTator, text mining | PubMed |
| Editorial: Insights in cardiovascular and smooth muscle pharmacology: 2023. | Front Pharmacol | 2024 | 39834824 | PubTator, text mining | PubMed |
| The Influence of Anti-ETAR and Anti-CXCR3 Antibody Levels on the Course of Specific Glomerulonephritis Types. | J Clin Med | 2024 | 39768675 | PubTator, text mining | PubMed |
| EDNRA regulates the tumour immune environment and predicts the efficacy and prognosis of cancer immunotherapy. | J Cell Mol Med | 2024 | 39601333 | PubTator, text mining | PubMed |
| Numerical investigation of the hydrodynamics of a submarine with pump-jet propulsor in oblique sailing under wave-current coupling. | Sci Rep | 2024 | 39558068 | PubTator, text mining | PubMed |
| Non-HLA Autoantibodies Against Angiotensin II Receptor 1 (AT1R) and Endothelin A Receptor (ETAR) in Pediatric Kidney Transplantation. | Int J Mol Sci | 2024 | 39519368 | PubTator, text mining | PubMed |
| Endothelin-1 receptor blockade impairs invasion patterns in engineered 3D high-grade serous ovarian cancer tumouroids. | Clin Sci (Lond) | 2024 | 39503511 | PubTator, text mining | PubMed |
| YAP signaling orchestrates the endothelin-1-guided invadopodia formation in high-grade serous ovarian cancer. | Biosci Rep | 2024 | 39495612 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1909/papers?page=7